TG THERAPEUTICS, INC. (TGTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q4 '17: 152K Q1 '18: 152K Q2 '18: 152K Q3 '18: 152K Q4 '18: 152K Q1 '19: 152K Q2 '19: 152K Q3 '19: 152K Q4 '19: 152K Q1 '20: 152K Q2 '20: 152K Q3 '20: 152K Q4 '20: 152K Q1 '21: 907K Q2 '21: 2.4M Q3 '21: 4.4M Q4 '21: 6.7M Q1 '22: 7.9M Q2 '22: 7M Q3 '22: 5M Q4 '22: 2.8M Q1 '23: 8.6M Q2 '23: 24.1M Q3 '23: 189.8M Q4 '23: 233.7M Q1 '24: 289.3M Q2 '24: 346.7M Q3 '24: 264.8M Q4 '24: 329M Q1 '25: 386.4M Q2 '25: 454.1M Q3 '25: 531.9M Q4 '25: 616.3M Q1 '26: 700.3M Q2 '26: 799.5M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 250M 500M 750M Q2 '23: 21.3M Q3 '23: 183.5M Q4 '23: 219.5M Q1 '24: 270.6M Q2 '24: 321.6M Q3 '24: 233.8M Q4 '24: 290.5M Q1 '25: 337.8M Q2 '25: 394.8M Q3 '25: 453.9M Q4 '25: 515.6M Q1 '26: 581.7M Q2 '26: 658.6M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-450M -300M -150M 0 150M 300M 450M Q4 '11: -882K Q1 '12: -18.3M Q2 '12: -21.1M Q3 '12: -23.8M Q4 '12: -26.9M Q1 '13: -13.2M Q2 '13: -16.7M Q3 '13: -18.7M Q4 '13: -23M Q1 '14: -26.9M Q2 '14: -32.2M Q3 '14: -45M Q4 '14: -55.7M Q1 '15: -62.7M Q2 '15: -67.9M Q3 '15: -64.3M Q4 '15: -63.2M Q1 '16: -62.6M Q2 '16: -61.5M Q3 '16: -72.6M Q4 '16: -79M Q1 '17: -92.6M Q2 '17: -105M Q3 '17: -111.7M Q4 '17: -118.7M Q1 '18: -132.6M Q2 '18: -59.9M Q3 '18: -62.6M Q4 '18: -85.7M Q1 '19: -78.8M Q2 '19: -158.7M Q3 '19: -185.2M Q4 '19: -169.1M Q1 '20: -184.6M Q2 '20: -199.9M Q3 '20: -224.8M Q4 '20: -273.6M Q1 '21: -312.6M Q2 '21: -339.2M Q3 '21: -338.6M Q4 '21: -344.8M Q1 '22: -322.4M Q2 '22: -283.9M Q3 '22: -233.7M Q4 '22: -218.3M Q1 '23: -188.4M Q2 '23: -194.2M Q3 '23: -44.4M Q4 '23: 20.6M Q1 '24: 48.4M Q2 '24: 101.8M Q3 '24: -505K Q4 '24: 41.9M Q1 '25: 59.8M Q2 '25: 85.8M Q3 '25: 102.8M Q4 '25: 123.3M Q1 '26: 149.5M Q2 '26: 136.3M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-400M -200M 0 200M 400M 600M Q1 '11: 2.3M Q2 '11: 124.4K Q3 '11: 54.5K Q4 '11: -853.1K Q1 '12: -11.1M Q2 '12: -12.7M Q3 '12: -15.2M Q4 '12: -18.1M Q1 '13: -11.5M Q2 '13: -16.2M Q3 '13: -18.3M Q4 '13: -20.5M Q1 '14: -24.4M Q2 '14: -29.8M Q3 '14: -42.6M Q4 '14: -55.8M Q1 '15: -62.8M Q2 '15: -67.9M Q3 '15: -64.1M Q4 '15: -62.9M Q1 '16: -62.2M Q2 '16: -61M Q3 '16: -72.2M Q4 '16: -78.3M Q1 '17: -92.1M Q2 '17: -104.6M Q3 '17: -111.3M Q4 '17: -118.5M Q1 '18: -132.3M Q2 '18: -148.1M Q3 '18: -150.5M Q4 '18: -173.5M Q1 '19: -167.1M Q2 '19: -159.2M Q3 '19: -187.2M Q4 '19: -172.9M Q1 '20: -188.8M Q2 '20: -205.5M Q3 '20: -230.7M Q4 '20: -279.4M Q1 '21: -318.9M Q2 '21: -344.5M Q3 '21: -343M Q4 '21: -348.1M Q1 '22: -326.5M Q2 '22: -288.5M Q3 '22: -238.7M Q4 '22: -223.8M Q1 '23: -194M Q2 '23: -201.1M Q3 '23: -51.4M Q4 '23: 12.7M Q1 '24: 41.2M Q2 '24: 95.7M Q3 '24: -14.4M Q4 '24: 23.4M Q1 '25: 39.1M Q2 '25: 60.5M Q3 '25: 447.5M Q4 '25: 447.2M Q1 '26: 461.9M Q2 '26: 441.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 50M 100M 150M Q2 '23: 2.8M Q3 '23: 6.3M Q4 '23: 14.1M Q1 '24: 18.7M Q2 '24: 25.1M Q3 '24: 30.9M Q4 '24: 38.5M Q1 '25: 48.6M Q2 '25: 59.2M Q3 '25: 78M Q4 '25: 100.7M Q1 '26: 118.7M Q2 '26: 140.9M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow TTM

-300M -150M 0 150M 300M 450M Q2 '12: -1.4M Q3 '12: -4.4M Q4 '12: -5.2M Q1 '13: -6.5M Q2 '13: -8.6M Q3 '13: -6.7M Q4 '13: -10.7M Q1 '14: -16.9M Q2 '14: -17.9M Q3 '14: -24.8M Q4 '14: -35.1M Q1 '15: -35.6M Q2 '15: -44.3M Q3 '15: -46.9M Q4 '15: -44.7M Q1 '16: -52.5M Q2 '16: -53.1M Q3 '16: -57.5M Q4 '16: -61.6M Q1 '17: -67.2M Q2 '17: -81.2M Q3 '17: -88.9M Q4 '17: -93.8M Q1 '18: -99.5M Q2 '18: -106.9M Q3 '18: -117.1M Q4 '18: -128.9M Q1 '19: -134.2M Q2 '19: -135.9M Q3 '19: -136.1M Q4 '19: -132.8M Q1 '20: -161.6M Q2 '20: -169.5M Q3 '20: -192.9M Q4 '20: -214.5M Q1 '21: -233.7M Q2 '21: -250.1M Q3 '21: -260.8M Q4 '21: -295.6M Q1 '22: -283M Q2 '22: -271.9M Q3 '22: -239.2M Q4 '22: -176.2M Q1 '23: -167.4M Q2 '23: -160.3M Q3 '23: -42.1M Q4 '23: -31.4M Q1 '24: 20.3M Q2 '24: 67.8M Q3 '24: -28.1M Q4 '24: -40.5M Q1 '25: -61M Q2 '25: -59.1M Q3 '25: -70.1M Q4 '25: -24.8M Q1 '26: -14M Q2 '26: 17.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-300M -150M 0 150M 300M 450M Q2 '12: -1.4M Q3 '12: -4.4M Q4 '12: -5.2M Q1 '13: -6.5M Q2 '13: -8.6M Q3 '13: -6.8M Q4 '13: -10.7M Q1 '14: -16.9M Q2 '14: -17.9M Q3 '14: -24.8M Q4 '14: -35.1M Q1 '15: -35.6M Q2 '15: -44.3M Q3 '15: -47M Q4 '16: -61.9M Q1 '17: -67.3M Q2 '17: -81.2M Q3 '17: -88.9M Q4 '17: -93.8M Q1 '18: -99.5M Q2 '18: -106.9M Q3 '18: -117.2M Q4 '18: -129M Q1 '19: -134.3M Q2 '19: -136M Q3 '19: -136.2M Q4 '19: -132.9M Q1 '20: -161.8M Q2 '20: -169.8M Q3 '20: -193.1M Q4 '20: -214.9M Q1 '21: -234.1M Q2 '21: -250.6M Q3 '21: -261.2M Q4 '21: -296M Q1 '22: -283.3M Q2 '22: -272.1M Q3 '22: -239.3M Q4 '22: -176.2M Q3 '24: -28.1M Q4 '24: -40.6M Q1 '25: -61.1M Q2 '25: -59.2M Q3 '25: -70.2M Q4 '25: -25M Q1 '26: -14.2M Q2 '26: 17.4M Q2 '13 Q4 '14 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '21: 131.9M Q2 '21: 132.1M Q3 '21: 132.4M Q1 '22: 134.4M Q2 '22: 134.8M Q3 '22: 135.3M Q1 '23: 140.3M Q2 '23: 141.5M Q3 '23: 155.9M Q1 '24: 146.2M Q2 '24: 159.4M Q3 '24: 160.7M Q1 '25: 162.8M Q2 '25: 162.6M Q3 '25: 161M Q1 '26: 160.1M Q2 '26: 157.3M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q4 '11: -0.44 Q1 '12: -2.42 Q2 '12: -2.43 Q3 '12: -2.58 Q4 '13: -0.81 Q1 '14: -0.89 Q2 '14: -0.96 Q3 '14: -1.31 Q4 '14: -1.60 Q1 '15: -1.70 Q2 '15: -1.72 Q3 '15: -1.49 Q4 '15: -1.38 Q1 '16: -1.31 Q2 '16: -1.26 Q3 '16: -1.48 Q4 '16: -1.59 Q1 '17: -1.83 Q2 '17: -1.95 Q3 '17: -1.93 Q4 '17: -1.91 Q1 '18: -1.98 Q2 '18: -0.94 Q3 '18: -0.89 Q4 '18: -1.11 Q1 '19: -0.95 Q2 '19: -1.96 Q3 '19: -2.22 Q4 '19: -1.98 Q1 '20: -2.03 Q2 '20: -2.08 Q3 '20: -2.12 Q4 '20: -2.40 Q1 '21: -2.61 Q2 '21: -2.73 Q3 '21: -2.65 Q4 '21: -2.63 Q1 '22: -2.45 Q2 '22: -2.16 Q3 '22: -1.77 Q4 '22: -1.64 Q1 '23: -1.41 Q2 '23: -1.45 Q3 '23: -0.46 Q4 '23: 0.09 Q1 '24: 0.30 Q2 '24: 0.68 Q3 '24: -0.03 Q4 '24: 0.14 Q1 '25: 0.24 Q2 '25: 0.37 Q3 '25: 2.78 Q4 '25: 2.78 Q1 '26: 2.87 Q2 '26: 2.75 Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.